Drugs that contain Nepafenac

1. List of Ilevro drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7947295 NOVARTIS Ophthalmic compositions containing a synergistic combination of two polymers
Jun, 2024

(1 year, 4 months from now)

US9662398 NOVARTIS Carboxylvinyl polymer-containing nanoparticle suspensions
Dec, 2030

(7 years from now)

US8921337 NOVARTIS Carboxyvinyl polymer-containing nanoparticle suspensions
Mar, 2032

(9 years from now)

Market Authorisation Date: 16 October, 2012

Treatment: NA

Dosage: SUSPENSION/DROPS;OPHTHALMIC

How can I launch a generic of ILEVRO before it's patent expiration?
More Information on Dosage

2. List of Nevanac drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8071648 NOVARTIS Topical nepafenac formulations
Dec, 2025

(2 years from now)

US8324281 NOVARTIS Topical nepafenac formulations
Dec, 2025

(2 years from now)

US7834059 NOVARTIS Topical nepafenac formulations
Jan, 2027

(4 years from now)

Market Authorisation Date: 19 August, 2005

Treatment: Method of treating ocular inflammation

Dosage: SUSPENSION/DROPS;OPHTHALMIC

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic